Chardan Healthcare Acquisition 2 Corp.

Chardan Healthcare Acquisition 2 Corp.

Chardan Healthcare Acquisition 2 Corp. operated as a special purpose acquisition company formed in 2020 by Chardan Capital Markets, an investment bank founded by Alex Lewis that focuses on life sciences and healthcare. The SPAC was created to identify and merge with a private healthcare company, leveraging Chardan's sector expertise. Wealth origin was not disclosed for this entity, as it was a financial sponsor vehicle rather than a family office. The strategy centered on acquiring a single healthcare business at a valuation between $500 million and $2 billion, with a focus on growth-stage biotech, diagnostics, or healthcare services. The SPAC did not hold a diversified portfolio; instead it placed IPO proceeds in a trust account, later seeking a target. It did not disclose any completed deals or co-investments. The SPAC raised $200 million in its February 2021 IPO, listed on Nasdaq under ticker CHDAU. It had additional offices in New York, London, Hong Kong, Turin, and Dallas. Without a completed merger, the SPAC was liquidated in 2023, returning funds to public shareholders (per SEC filings, 2023). Chardan Healthcare Acquisition 2 Corp. differed from operating companies in that it had no ongoing business operations. Its structure was purely a vehicle to facilitate a reverse merger. The SPAC's failure to close a deal highlights the risk of time-bound mandates for blank-check vehicles.